On September 10, the Food and Drug Administration (FDA) Biocompatibility and Toxicology Program published a statement announcing its intention to commission an independent literature review and internal bench laboratory study...more
9/26/2024
/ Class Action ,
Consumer Protection Laws ,
Final Rules ,
Food Manufacturers ,
Jurisdiction ,
Labeling ,
Medical Devices ,
Medical Research ,
Metals ,
Misleading Statements ,
Peer Review ,
Preemption ,
Premarket Approval Applications ,
Proposition 65 ,
Research Reports
Recently, Venable's Government Division offered its general thoughts on the fallout from the Supreme Court's reversal of the long-standing Chevron deference principle. Here, the FDA Practice Group offers some of its own...more
7/11/2024
/ Administrative Procedure Act ,
Biologics Price Competition and Innovation Act of 2009 ,
Chevron Deference ,
Federal Food Drug and Cosmetic Act (FFDCA) ,
Food and Drug Administration (FDA) ,
Government Agencies ,
Jurisdiction ,
Loper Bright Enterprises v Raimondo ,
Prescription Drugs ,
Public Health Service Act ,
Rulemaking Process ,
SCOTUS ,
Statutory Interpretation